Clinical Trials for NSCLC Stage IV

Find clinical trials for nsclc stage iv. Discover research opportunities and treatment options in your area.

39 Active Trials Found

Showing 39 trials on this page

Page 1 of 2

A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)

NCT ID: NCT05429320

This clinical trial is investigating a treatment called local ablative therapy (LAT) for patients with advanced non-small cell lung cancer (NSCLC) who have rising levels of minimal residual disease...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Middletown, New Jersey, United States +9 more

Prophylactic Peptide Vaccine in Advanced ALK+ NSCLC

NCT ID: NCT05950139

This clinical trial is studying a new cancer vaccine designed to help patients with advanced ALK-positive non-small cell lung cancer (NSCLC). The goal is to see if this vaccine can safely prevent o...

Recruiting

Phase: PHASE1 Type: interventional Locations: Baltimore, Maryland, United States

Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations

NCT ID: NCT05701787

This clinical trial is focused on studying a type of lung cancer called non-small-cell lung cancer (NSCLC), specifically looking at patients who have rare genetic mutations. These mutations can aff...

Recruiting

Type: observational Locations: Shanghai, Shanghai, China

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

NCT ID: NCT05657873

This clinical trial is studying a new treatment approach for people with advanced non-small cell lung cancer (NSCLC) that has spread to the liver. The researchers want to find out if adding a speci...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Allentown, Pennsylvania, United States +7 more

Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer

NCT ID: NCT05652868

This clinical trial is studying a new treatment called MYTX-011 for patients with non-small cell lung cancer (NSCLC), a common type of lung cancer. The goal of the trial is to understand how safe a...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Milwaukee, Wisconsin, United States +86 more

Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases

NCT ID: NCT06401824

This clinical trial is studying a combination of two medications, sacituzumab govitecan (SG) and bevacizumab, to see if they can help shrink brain metastases in patients with advanced non-small cel...

Recruiting

Phase: PHASE2 Type: interventional Locations: Maastricht, , Netherlands, Groningen, , Netherlands +1 more

ResQ201A: Clinical Trial Of N-803 Plus TISLELIZUMAB And DOCETAXEL Versus DOCETAXEL Monotherapy In Participants With Advanced Or Metastatic Non-Small Cell Lung Cancer

NCT ID: NCT06745908

This clinical trial, called ResQ201A, is studying a new treatment option for patients with advanced or metastatic non-small cell lung cancer (NSCLC), specifically those at Stage IV. Researchers wan...

Recruiting

Phase: PHASE3 Type: interventional Locations: Glendale, California, United States, Los Alamitos, California, United States

SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors

NCT ID: NCT04767009

This clinical trial is investigating the use of a specific type of radiation therapy called Stereotactic Body Radiation Therapy (SBRT) for patients with a type of lung cancer known as Stage IV Non-...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, , China, Shanghai, Shanghai, China

Lung Cancer Registry

NCT ID: NCT04654364

**Lung Cancer Registry Trial Summary** This clinical trial, called the Lung Cancer Registry, aims to gather important information about patients with lung cancer, specifically those with advanced ...

Recruiting

Type: observational Locations: Linz, Oberösterreich, Austria, Innsbruck, Tirol, Austria +2 more

Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG)

NCT ID: NCT05281406

The PACE-LUNG trial is studying whether adding chemotherapy to the medication osimertinib can improve treatment outcomes for patients with advanced lung cancer (non-small cell lung cancer or NSCLC)...

Recruiting

Phase: PHASE2 Type: interventional Locations: Frankfurt, , Germany, Mainz, , Germany +14 more

Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma

NCT ID: NCT05303493

This clinical trial is exploring whether a natural substance called Camu Camu, which may help improve gut health, can enhance the effectiveness of certain cancer treatments for patients with advanc...

Recruiting

Phase: PHASE1 Type: interventional Locations: Montreal, Quebec, Canada, Montréal, Quebec, Canada +1 more

Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC

NCT ID: NCT06219317

This clinical trial is studying a treatment called cemiplimab for patients with stage IV non-small cell lung cancer (NSCLC) that has spread to a limited number of sites in the body. The goal is to ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Brussels, , Belgium, Maastricht, , Netherlands +15 more

Outpatient Pulmonary Rehabilitation in Non-small-cell Lung Cancer Receiving Immunotherapy

NCT ID: NCT06436625

This clinical trial is studying the impact of an outpatient pulmonary rehabilitation program on patients with advanced non-small-cell lung cancer (NSCLC) who are receiving immunotherapy. The main g...

Recruiting

Phase: NA Type: interventional Locations: Vienna, , Austria

AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer

NCT ID: NCT06788366

The AI-HOPE Lung Cancer trial is exploring how artificial intelligence can help predict how well patients with advanced non-small cell lung cancer (NSCLC) will respond to specific treatments, such ...

Recruiting

Type: observational Locations: Milan, , Italy

Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC

NCT ID: NCT06552234

This clinical trial is studying a new treatment called repotrectinib for patients with advanced non-small cell lung cancer (NSCLC) that has a specific genetic change known as ROS1 rearrangement. Th...

Recruiting

Phase: PHASE2 Type: interventional Locations: Angers, , France, Rennes, , France +21 more

Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC

NCT ID: NCT04467723

This clinical trial is investigating whether adding a medication called pirfenidone to another medication called atezolizumab can help improve treatment outcomes for patients with advanced non-smal...

Recruiting

Phase: PHASE1 Type: interventional Locations: Fairway, Kansas, United States, Kansas City, Kansas, United States

A Biomarker Screening Protocol for Participants With Solid Tumors

NCT ID: NCT05891197

**Clinical Trial Summary: Biomarker Screening for Solid Tumors** This clinical trial is focused on a screening process that helps identify patients with specific types of solid tumors, such as adv...

Enrolling by invitation

Type: observational Locations: Rocky Mount, North Carolina, United States, Rocky Mount, North Carolina, United States

Cancer Patient Remote Monitoring for Timely Communication Study

NCT ID: NCT06623786

This clinical trial, called the Cancer Patient Remote Monitoring for Timely Communication Study, is looking into how remote monitoring can help patients with advanced lung cancer (specifically stag...

Not yet recruiting

Type: observational

Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer

NCT ID: NCT06523673

This clinical trial is looking at a treatment called Stereotactic Body Radiotherapy (SBRT) for patients with a specific type of lung cancer known as metastatic non-small cell lung cancer (NSCLC) th...

Recruiting

Phase: PHASE3 Type: interventional Locations: Hangzhou, Zhejiang, China

Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Active Brain Metastasis

NCT ID: NCT06501378

This clinical trial is investigating a new treatment approach for patients with stage IV non-small cell lung cancer (NSCLC) who also have active brain metastasis, which means the cancer has spread ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, , China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions